发明名称 HETERODIMERS OF GLUTAMIC ACID
摘要 Compounds of Formula (Ia), wherein R is a C<SUB>6</SUB>-C<SUB>12</SUB> substituted or unsubstituted aryl, a C<SUB>6</SUB>-C<SUB>12</SUB> substituted or unsubstituted heteroaryl, a C<SUB>1</SUB>-C<SUB>6</SUB> substituted or unsubstituted alkyl or -NR'R', Q is C(O), O, NR', S, S(O)<SUB>2</SUB>, C(O)<SUB>2</SUB> (CH2)p Y is C(O), O, NR', S, S(O)<SUB>2</SUB>, C(O)<SUB>2</SUB> (CH2)p Z is H or C<SUB>1</SUB>-C<SUB>4</SUB> alkyl, R' is H, C(O), S(O)<SUB>2</SUB>, C(O)<SUB>2</SUB>, a C<SUB>6</SUB>-C<SUB>12</SUB> substituted or unsubstituted aryl, a C<SUB>6</SUB>-C<SUB>12</SUB> substituted or unsubstituted heteroaryl or a C<SUB>1</SUB>-C<SUB>6</SUB> substituted or unsubstituted alkyl, when substituted, aryl, heteroaryl and alkyl are substituted with halogen, C<SUB>6</SUB>-C<SUB>12</SUB> heteroaryl, -NR'R' or COOZ, which have diagnostic and therapeutic properties, such as the treatment and management of prostate cancer and other diseases related to NAALADase inhibition. Radiolabels can be incorporated into the structure through a variety of prosthetic groups attached at the X amino acid side chain via a carbon or hetero atom linkage.
申请公布号 WO2008058192(A3) 申请公布日期 2008.09.12
申请号 WO2007US83934 申请日期 2007.11.07
申请人 MOLECULAR INSIGHT PHARMACEUTICALS, INC.;BABICH, JOHN, W.;ZIMMERMAN, CRAIG, N.;MARESCA, KEVIN, P. 发明人 BABICH, JOHN, W.;ZIMMERMAN, CRAIG, N.;MARESCA, KEVIN, P.
分类号 A61K51/00 主分类号 A61K51/00
代理机构 代理人
主权项
地址